Celtic Pharma acquired Xenova thus strengthening itself with vaccines for treating drug addiction. The deal could be worth up to £26.1 M (US$47.5 M) to Xenova.
Emergent BioSolutions acquired MicroScience thus strengthening its product portfolio with five clinical-stage vaccines targeting infectious diseases along with proprietary platform technologies.